Catheter ablation of atrial fibrillation to reduce stroke risk

Zurück zum Zitat Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988PubMedCrossRef Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988PubMedCrossRef

Zurück zum Zitat Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 12(10):1360–1420PubMedCrossRef Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 12(10):1360–1420PubMedCrossRef

Zurück zum Zitat Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation * developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–2747PubMedCrossRef Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation * developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–2747PubMedCrossRef

Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272PubMedCrossRef Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272PubMedCrossRef

Zurück zum Zitat Weerasooriya R, Khairy P, Litalien J et al (2011) Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57(2):160–166PubMedCrossRef Weerasooriya R, Khairy P, Litalien J et al (2011) Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57(2):160–166PubMedCrossRef

Zurück zum Zitat Ouyang F, Tilz R, Chun J et al (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 122(23):2368–2377PubMedCrossRef Ouyang F, Tilz R, Chun J et al (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 122(23):2368–2377PubMedCrossRef

Zurück zum Zitat Carlsson J, Miketic S, Windeler J et al (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41(10):1690–1696PubMedCrossRef Carlsson J, Miketic S, Windeler J et al (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41(10):1690–1696PubMedCrossRef

Zurück zum Zitat Corley SD, Epstein AE, DiMarco JP et al (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 109(12):1509–1513PubMedCrossRef Corley SD, Epstein AE, DiMarco JP et al (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 109(12):1509–1513PubMedCrossRef

Zurück zum Zitat Tsadok MA, Jackevicius CA, Essebag V et al (2012) Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 126(23):2680–2687PubMedCrossRef Tsadok MA, Jackevicius CA, Essebag V et al (2012) Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 126(23):2680–2687PubMedCrossRef

Zurück zum Zitat Chao TF, Lin YJ, Tsao HM et al (2011) CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 58(23):2380–2385PubMedCrossRef Chao TF, Lin YJ, Tsao HM et al (2011) CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 58(23):2380–2385PubMedCrossRef

Zurück zum Zitat Bunch TJ, Crandall BG, Weiss JP et al (2011) Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22(8):839–845PubMedCrossRef Bunch TJ, Crandall BG, Weiss JP et al (2011) Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22(8):839–845PubMedCrossRef

Zurück zum Zitat Hunter RJ, McCready J, Diab I et al (2012) Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 98(1):48–53PubMedCrossRef Hunter RJ, McCready J, Diab I et al (2012) Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 98(1):48–53PubMedCrossRef

Zurück zum Zitat Oral H, Chugh A, Ozaydin M et al (2006) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114(8):759–765PubMedCrossRef Oral H, Chugh A, Ozaydin M et al (2006) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114(8):759–765PubMedCrossRef

Zurück zum Zitat Themistoclakis S, Corrado A, Marchlinski FE et al (2010) The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 55(8):735–743PubMedCrossRef Themistoclakis S, Corrado A, Marchlinski FE et al (2010) The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 55(8):735–743PubMedCrossRef

Zurück zum Zitat Saad EB, d’Avila A, Costa IP et al (2011) Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score </= 3: a long-term outcome study. Circ Arrhythm Electrophysiol 4(5):615–621PubMedCrossRef Saad EB, d’Avila A, Costa IP et al (2011) Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score </= 3: a long-term outcome study. Circ Arrhythm Electrophysiol 4(5):615–621PubMedCrossRef

Zurück zum Zitat Lin YJ, Chao TF, Tsao HM et al (2012) Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace Lin YJ, Chao TF, Tsao HM et al (2012) Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace

Zurück zum Zitat Hussein AA, Saliba WI, Martin DO et al (2011) Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol 4(3):271–278PubMedCrossRef Hussein AA, Saliba WI, Martin DO et al (2011) Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol 4(3):271–278PubMedCrossRef

Zurück zum Zitat Yagishita A, Takahashi Y, Takahashi A et al (2011) Incidence of late thromboembolic events after catheter ablation of atrial fibrillation. Circ J 75(10):2343–2349PubMedCrossRef Yagishita A, Takahashi Y, Takahashi A et al (2011) Incidence of late thromboembolic events after catheter ablation of atrial fibrillation. Circ J 75(10):2343–2349PubMedCrossRef

Zurück zum Zitat Verma A, Champagne J, Sapp J et al (2012) Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. Arch Intern Med 2012:1–8 Verma A, Champagne J, Sapp J et al (2012) Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. Arch Intern Med 2012:1–8

Zurück zum Zitat Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367(21):1979–1987PubMedCrossRef Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367(21):1979–1987PubMedCrossRef

Zurück zum Zitat Becattini C, Agnelli G, Schenone A et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366(21):1959–1967PubMedCrossRef Becattini C, Agnelli G, Schenone A et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366(21):1959–1967PubMedCrossRef

Zurück zum Zitat Mant J, Hobbs FD, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493–503PubMedCrossRef Mant J, Hobbs FD, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493–503PubMedCrossRef

Zurück zum Zitat Calkins H, Kuck KH, Cappato R et al (2012) 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American college of cardiology foundation, the American heart association, the European cardiac arrhythmia society, the European Heart Rhythm Association, the society of thoracic surgeons, the Asia pacific heart rhythm society, and the heart rhythm society. Europace Calkins H, Kuck KH, Cappato R et al (2012) 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American college of cardiology foundation, the American heart association, the European cardiac arrhythmia society, the European Heart Rhythm Association, the society of thoracic surgeons, the Asia pacific heart rhythm society, and the heart rhythm society. Europace

Zurück zum Zitat Daoud EG, Glotzer TV, Wyse DG et al (2011) Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 8(9):1416–1423PubMedCrossRef Daoud EG, Glotzer TV, Wyse DG et al (2011) Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 8(9):1416–1423PubMedCrossRef

Zurück zum Zitat Healey JS, Connolly SJ, Gold MR et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129PubMedCrossRef Healey JS, Connolly SJ, Gold MR et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120–129PubMedCrossRef

Zurück zum Zitat Welles CC, Whooley MA, Na B et al (2011) The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the heart and soul study. Am Heart J 162(3):555–561PubMedCrossRef Welles CC, Whooley MA, Na B et al (2011) The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the heart and soul study. Am Heart J 162(3):555–561PubMedCrossRef